Chinese Journal of New Drugs Articles

Articles>Articles Overview

1System framework study of the sustainable innovation policy on biomedicine in ChinaHAN Peng, WU Zhi-ang1-11

2Enlightenment from the creation of the first-in-class drug sotorasibGUO Zong-ru12-17

3The current situation of instructions regarding storage conditions of marketed Chinese patent medicines and the discussions on related problemsZHOU Yue-hua, SONG Min-xian, SHEN Xiang-rong, HOU Peng, LI Tian-quan, LIU Ji-hong, SONG Zong-hua18-26

4Analysis on the clinical trials of human fibrinogen on the market abroadWANG Yan-lin, RAO Ya-lan, XIONG Wen-xiang, YU Ai-ping, GAO Chen-yan27-32

5The value and approaches of Chinese herbal medicine R&D against broad-spectrum respiratory virusLI Bing, ZHANG Hong-chun, YANG Zi-feng, DUAN Da-yue, LIU Jun, WANG Zhong, WANG Yong-yan33-38

6Embryo-fetal developmental toxicity and toxicokinetics of Fuke Zaizao Capsules in rabbitsZHOU Li, CHONG Li-ming, WANG Zhong-hui, WANG Qin-xia, XU Li, YANG Yang, JIA Yu-ling, WANG Fen, MAO Xiao-yan, SUN Zu-yue39-45

7Research advances on autophagy mechanism of bidirectional regulation by berberineLUO Yu-ping, HUANG Zhi-ying, ZHANG He-zhan, LI Wei46-52

8Urinary biomarkers of cisplatin-induced acute kidney injury in Beagle dogsBAI Yu-jie, HUO Gui-tao, YANG Yan-wei, SUN Li, MIAO Yu-fa, ZHOU Xiao-bing, LI Bo53-60

9The research progress of small molecule immuno-oncology therapeutic agentsHUANG Yao-qing, LIU Li-li, LI Zi-yan, WANG Chun-li, MAO Yan-yan61-68

10Global research and development of COVID-19 vaccine and therapeutics: status and trendZHENG Nan, ZHAO Ming, TIAN Xiao-xin, CHEN Di, ZHANG Ya-tong, JIN Peng-fei69-76

11Analysis and countermeasures of common problems found during monitoring on investigator initiated trialsQU Tian-tian, ZHOU Zhi-gang, YUAN Yan, QIAN Bi-yun, LI Qiang, Lü Wen-wen, FENG Tie-nan77-81

12Determination of piceatannol 3 '-O-glucoside in the plasma of Beagle dogs using LC-MS/MS and its pharmacokinetic researchWANG Qing, LIU Jun-feng, GU Liu-ge, CHEN Yun-jian, QIN Yan82-88

13Preparation and in vitro evaluation of phillyrin-loaded exosomal drug delivery systemLü Tian-tian, YU Hai-yan, XUE Bing-quan, YU Xiao-yu, ZHANG Yan, YU Ya-hui, HUANG Hai-ying89-94

14Risk signal mining related to belatacept based on the US Food and Drug Administration Adverse Event Reporting SystemGUO Ming-xing, HOU Wen-jing, ZHAO Ying, ZHANG Zhi-qi, ZHAO Xiao-hong, XU Wan-yi, CUI Xiang-li95-101